Old Web
English
Sign In
Acemap
>
authorDetail
>
Kristin N. Kelly
Kristin N. Kelly
Pfizer
Biochemistry
Chemistry
Cyclin-dependent kinase 5
Organic chemistry
Cyclin-dependent kinase 2
3
Papers
236
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Potent and cellularly active 4-aminoimidazole inhibitors of cyclin-dependent kinase 5/p25 for the treatment of Alzheimer's disease.
2009
Bioorganic & Medicinal Chemistry Letters
Christopher John Helal
Zhijun Kang
John C. Lucas
Thomas G. Gant
Michael K. Ahlijanian
Joel B. Schachter
Karl E.G. Richter
James M Cook
Frank S. Menniti
Kristin N. Kelly
Scot Mente
Jay Pandit
Natalie Hosea
Show All
Source
Cite
Save
Citations (32)
Discovery and SAR of 2-aminothiazole inhibitors of cyclin-dependent kinase 5/p25 as a potential treatment for Alzheimer's disease.
2004
Bioorganic & Medicinal Chemistry Letters
Christopher John Helal
Mark A. Sanner
Christopher B. Cooper
Thomas G. Gant
Mavis Diane Adam
John C. Lucas
Zhijun Kang
Stanley William Kupchinsky
Michael K. Ahlijanian
Bonnie Frances Tate
Frank S. Menniti
Kristin N. Kelly
Marcia Peterson
Show All
Source
Cite
Save
Citations (92)
Atropisomeric quinazolin-4-one derivatives are potent noncompetitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonists
2001
Bioorganic & Medicinal Chemistry Letters
Willard Mckowan Welch
Frank E. Ewing
J. Huang
Frank S. Menniti
Martin J. Pagnozzi
Kristin N. Kelly
Patricia A. Seymour
Victor Guanowsky
S Guhan
M.R Guinn
D Critchett
John T. Lazzaro
Alan H. Ganong
Keith Michael Devries
T.L Staigers
Bertrand Leo Chenard
Show All
Source
Cite
Save
Citations (112)
1